ABO and Alzheimer disease: We previously demonstrated that, despite having AD‐like pathology, NDAN brains exhibited key differences from AD patient brains, including preserved synaptic function, distinct proteomic and miRNA profiles, enhanced neurogenesis, improved antioxidant defenses, preserved autophagy, and synaptic resistance to toxic AβO and TauO.8, 9, 11, 12, 14